Navigation Links
Fuisz Pharma Announces Novel Anti Abuse System for Opiates
Date:1/27/2010

MIAMI and LJUBLJANA, Slovenia, Jan. 27 /PRNewswire/ -- Fuisz Pharma today announced the development of a novel anti-abuse system intended for use with abuse prone drugs. This system seeks to address the misuse of addictive drugs with a particular emphasis on opiates and is applicable to all dosage forms.

Fuisz Pharma President, Joseph Matus Fuisz commented: "The desirability of an effective anti abuse system is well understood. The United States Government has estimated that thirty six million Americans will abuse a medication at some point in their lifetime. Abuse is particularly prevalent in the pain area. Notwithstanding this need, the industry has found it challenging to implement abuse resistant dosage forms despite Herculean formulation efforts. This is due primarily to the fundamental tension between the bioavailability of a drug in the body and the prevention of extraction from the dosage form and other types of misuse by a highly motivated and sophisticated population of abusers."

Mr. Fuisz continued: "The Fuisz system for preventing abuse combines, as the best inventions do, novelty with simplicity. We are confident that our anti-abuse system will be welcomed by our pharmaceutical partners as well as by those concerned with drug misuse issues and the public and private health practitioner."

Noted pharmaceutical inventor Richard C. Fuisz, M.D. (http://en.wikipedia.org/wiki/Richard_Carl_Fuisz) was one of the inventors of the methodology.

Fuisz Pharma is a private pharmaceutical company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery (orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, etc.) and have extensive experience working with big and specialty pharma. Fuisz Pharma has offices in Miami and Los Angeles as well as a presence in the EU through Ljubljana, Slovenia.

SOURCE Fuisz Pharma


'/>"/>
SOURCE Fuisz Pharma
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
2. Pharma CI Conference Amy Yueh Pays $52,000 to Apaporis LLC to Satisfy Judgment Against Her In Superior Court Of New Jersey Case
3. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
4. Intercept Pharmaceuticals Raises $25 Million Series B Financing
5. Pharma Billionaire Stewart Rahr Provides Substantial Donation to Haiti Charities
6. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
7. Amylin Pharmaceuticals to Webcast Year-End Financial Results
8. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
9. New Life Agency, Inc. Joins Forces With The Diamond Institute and Walgreens Specialty Pharmacy to Introduce the Nations First In Vitro Fertilization Insurance Program
10. New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
11. Sagent Pharmaceuticals Launches Pamidronate Disodium Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , February 22, 2017 According to a ... Forceps, Trocar, SIMS, CUSCO), Application (Laparoscopy, Colposcopy, Hysteroscopy, D&C, Ablation, Biopsy), ... to 2021", published by MarketsandMarkets, the global market is expected to ... 2016, at a CAGR of 7.1% during the forecast period. ... ...
(Date:2/22/2017)... Feb 22, 2017 Research and Markets ... Development Pipeline Review, 2016" report to their offering. ... Dermatological ... worldwide, and approximately one-third of the US population suffers from ... the majority of the dermatology market has remained saturated with ...
(Date:2/22/2017)... , February 22, 2017 A research ... North America and the continuously changing landscape of ... in 2016 in the North America , a ... to increase to $21.6 billion by the year 2021 representing a ... the United States and Canada ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... The Waismann Method® ... of individuals who have recently fallen victim to America’s opioid epidemic. Now, opiate dependent ... California, where they are free from the shame, stigma, and harmful labeling ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as ... helps transform the HCC Risk Adjustment process from a typical fragmented process ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... serum, “NANOCALM 300” Microemulsified Hemp Extract. This premier nanoemulsified CBD product utilizes ... into the bloodstream. Far outpacing the absorption speed of all other ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the leading ... Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” http://www.beckersspine.com/spine-leaders/item/35348- ... in Michigan performing minimally invasive back surgery that often results in less post-operative ...
(Date:2/22/2017)... ... February 22, 2017 , ... The SeniorCare Investor will ... Forecast —on Thursday, February 23, 2017, at 1:00 PM ET. A recording of the ... of the Interactive Webinar Series. , If you want to find out what really ...
Breaking Medicine News(10 mins):